The Earlham Institute is expected to contribute around £4 billion to the global economy over the next 10 years, according to a new socioeconomic impact report on the Norwich-based research institute. With an anticipated return of nearly £13 globally for every £1 invested over the same time period, the report highlights the impact of the Norwich-based Institute’s diverse research, innovation and training activities....
A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times. The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid tumours. Traditional 2D models that are currently used fail to reproduce the complexity of the tumour’s microenvironment...
ExcellGene SA, privately held and founded 2001, offers services in research, development and manufacturing for the biopharmaceutical industry. The Company announces its role in the recently approved consortium funding through the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership of public, private, philanthropic and civil society organisations founded to develop vaccines against future epidemics...
The only UK-based manufacturer of World Health Organisation accredited vaccine fridges, Dulas Limited, has secured a funding package from HSBC UK to ramp up the development of its solar powered vaccine refrigeration units. The funding will allow the Welsh firm to meet extra demand from UN agencies and NGOs supporting low-income countries that remain in the early stages of Covid-19 vaccination programmes.
FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D facility’s footprint, the new state-of-the-art center enables the Company to expand its capabilities in cutting-edge discovery research, bioproduction, cell and gene therapy, Assisted Reproductive Technologies (ART) and cytogenetics...
PerkinElmer, Inc. has announced it has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital, a leading growth-oriented private equity firm, for total consideration of $2.45 billion in cash, $2.30 billion of which will be received at the closing and $150 million of which will be payable contingent on the exit valuation New Mountain Capital receives on a sale or other capital events related to the business...
It’s competition time at INTEGRA Biosciences, and the company is giving away the world’s most affordable and portable 96 channel pipette! The innovative MINI 96 electronic pipette is designed to help busy labs fill 96 and 384 plates faster and more precisely than traditional handheld pipettes, accelerating the efficiency of liquid handling protocols. With this instrument, users can enjoy accurate and reproducible pipetting of entire or partial plates, while minimizing the strain of repetitive tasks...
InnovaPrep Concentrating Pipette Select Automated Bio-Concentrator used for the International Space Station! The Concentrating Pipette Select uses dead-end filtration with single-use Concentrating Pipette tips to capture microorganisms from fluid samples. A patented process called Wet Foam Elution is then used to recover the microorganisms into sample volumes that closely match the input volumes of modern molecular methods such as qPCR in minutes...
Paragraf® announces Innovate UK Biomedical Catalyst grant award to develop the first proof of concept graphene-based diagnostic test to immediately identify patients who need an antibiotic treatment. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care...
Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care....
VectorBuilder Inc. – a leading provider of gene delivery solutions – has announced its plan to invest $30 million to build an ‘AAV Superbank’ for the research and drug discovery community. The company will develop a comprehensive collection of novel adeno-associated virus (AAV) capsids capable of targeting all the major tissues of therapeutic relevance, and deposit their sequences in the Superbank along with detailed biodistribution data. This bank will be made public, allowing free non-profit research use and license-based for-profit use...
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug discovery and development programmes...
TESCAN ORSAY HOLDING a.s. announces the installation of the AMBER X focused ion beam-scanning electron microscope (FIB-SEM) at the Institute for Factory Automation and Production Systems (FAPS) in Germany. The AMBER X offers a unique combination of plasma FIB with ultra-high resolution (UHR) field emission SEM for multiscale materials characterization. FAPS is using the FIB-SEM for research that will help to improve products used in a wide variety of industries...
At Achema (Frankfurt August 22-26, 2022), Telstar will be promoting the latest innovative developments in both in line management devices and process analytical technology for pharmaceutical freeze-drying systems and aseptic manufacturing processes, together with integrated process equipment and laboratory integrated management systems. In the Laboratory field, Telstar will be promoting BiOptima IT, the first biological safety cabinet protected with ZEROCOAT, a new coating with an antimicrobial barrier proven to reduce cleaning and maintenance costs...
Asynt report how Revive Eco (Glasgow, Scotland) are using their ReactoMate ATOM jacketed lab reactor and CondenSyn MAXI system to scale-up an innovative patent-pending process that allows them to strip out an oil from waste coffee grounds which has a very similar fatty acid profile to palm oil. Coffee is one of the most popular drinks worldwide with around two billion cups consumed every day...
Azenta Life Sciences has expanded its current multiomics services to include Olink technology, which ensures robust, multiplex protein biomarker analysis of samples in a CAP/CLIA laboratory environment. Azenta has a global footprint offering an end-to-end solution, from sample procurement and storage to sample analysis, enabling biopharma companies to accelerate scientific research...
Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS?CoV?2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can increase the stability and shelf life of complex biotherapeutics, like vaccines...
For the 27th time, the Hamburg-based life sciences company Eppendorf SE is awarding its prestigious research prize this year. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Thi Hoang Duong Nguyen, MRC Laboratory of Molecular Biology, Cambridge, UK as the winner of the Eppendorf Award for Young European Investigators 2022....
Russell Green, Lead Product Manager for Drug Discovery and SynBio at Automata outlines the four biggest trends in lab automation. Around the world, labs are full of highly trained scientists eager to make breakthrough discoveries. However, tedious tasks and shallow levels of data are currently preventing them from utilising their knowledge to its fullest capacity. At SLAS Europe last month, it was evident that...
Agilent Technologies Inc., announce that the FDA has approved a content uniformity (CU) method using the Agilent TRS100 Raman quantitative pharmaceutical analysis system. The submitting company, Teva Pharmaceutical Industries Ltd., is an Agilent Raman spectroscopy customer and global leader in generic and biopharmaceuticals. In 2021, the U.S. Food and Drug Administration (FDA) approved the company’s CU method application, which was developed using the TRS100 system...
Successful proof of concept proves analytical methods can be transferred securely between companies via cloud tackle the reproducibility crisis and advance digital transformation in R&D. The Pistoia Alliance is announcing that it has successfully completed a proof of concept (PoC) on the digital transfer via cloud of analytical High Performance Liquid Chromatography (HPLC) methods, proving it is possible to move analytical methods securely between two different vendors and Chromatography Data Systems (CDS) vendors with ease...
Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to meet the global demand for agarose resins. With this significant investment, the company will be able to manufacture and deliver continuous supply of high-quality agarose resins to develop and implement cost-effective, robust, and scalable production processes supporting novel therapies worldwide including the mRNA based Covid-19 vaccines.
The Earlham Institute is expected to contribute around £4 billion to the global economy over the next 10 years, according to a new socioeconomic impact report on the Norwich-based research institute. With an anticipated return of nearly £13 globally for every £1 invested over the same time period, the report highlights the impact of the Norwich-based Institute’s diverse research, innovation and training activities....
A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times. The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid tumours. Traditional 2D models that are currently used fail to reproduce the complexity of the tumour’s microenvironment...
ExcellGene SA, privately held and founded 2001, offers services in research, development and manufacturing for the biopharmaceutical industry. The Company announces its role in the recently approved consortium funding through the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership of public, private, philanthropic and civil society organisations founded to develop vaccines against future epidemics...
The only UK-based manufacturer of World Health Organisation accredited vaccine fridges, Dulas Limited, has secured a funding package from HSBC UK to ramp up the development of its solar powered vaccine refrigeration units. The funding will allow the Welsh firm to meet extra demand from UN agencies and NGOs supporting low-income countries that remain in the early stages of Covid-19 vaccination programmes.
FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D facility’s footprint, the new state-of-the-art center enables the Company to expand its capabilities in cutting-edge discovery research, bioproduction, cell and gene therapy, Assisted Reproductive Technologies (ART) and cytogenetics...
PerkinElmer, Inc. has announced it has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital, a leading growth-oriented private equity firm, for total consideration of $2.45 billion in cash, $2.30 billion of which will be received at the closing and $150 million of which will be payable contingent on the exit valuation New Mountain Capital receives on a sale or other capital events related to the business...
It’s competition time at INTEGRA Biosciences, and the company is giving away the world’s most affordable and portable 96 channel pipette! The innovative MINI 96 electronic pipette is designed to help busy labs fill 96 and 384 plates faster and more precisely than traditional handheld pipettes, accelerating the efficiency of liquid handling protocols. With this instrument, users can enjoy accurate and reproducible pipetting of entire or partial plates, while minimizing the strain of repetitive tasks...
InnovaPrep Concentrating Pipette Select Automated Bio-Concentrator used for the International Space Station! The Concentrating Pipette Select uses dead-end filtration with single-use Concentrating Pipette tips to capture microorganisms from fluid samples. A patented process called Wet Foam Elution is then used to recover the microorganisms into sample volumes that closely match the input volumes of modern molecular methods such as qPCR in minutes...
Paragraf® announces Innovate UK Biomedical Catalyst grant award to develop the first proof of concept graphene-based diagnostic test to immediately identify patients who need an antibiotic treatment. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care...
Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, announces a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes. The test will be the first in a pipeline of affordable, portable, easy-to-use, graphene-based IVD products, which will at least match the performance of the most advanced hospital laboratory, but at the point of care....
VectorBuilder Inc. – a leading provider of gene delivery solutions – has announced its plan to invest $30 million to build an ‘AAV Superbank’ for the research and drug discovery community. The company will develop a comprehensive collection of novel adeno-associated virus (AAV) capsids capable of targeting all the major tissues of therapeutic relevance, and deposit their sequences in the Superbank along with detailed biodistribution data. This bank will be made public, allowing free non-profit research use and license-based for-profit use...
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug discovery and development programmes...
TESCAN ORSAY HOLDING a.s. announces the installation of the AMBER X focused ion beam-scanning electron microscope (FIB-SEM) at the Institute for Factory Automation and Production Systems (FAPS) in Germany. The AMBER X offers a unique combination of plasma FIB with ultra-high resolution (UHR) field emission SEM for multiscale materials characterization. FAPS is using the FIB-SEM for research that will help to improve products used in a wide variety of industries...
At Achema (Frankfurt August 22-26, 2022), Telstar will be promoting the latest innovative developments in both in line management devices and process analytical technology for pharmaceutical freeze-drying systems and aseptic manufacturing processes, together with integrated process equipment and laboratory integrated management systems. In the Laboratory field, Telstar will be promoting BiOptima IT, the first biological safety cabinet protected with ZEROCOAT, a new coating with an antimicrobial barrier proven to reduce cleaning and maintenance costs...
Asynt report how Revive Eco (Glasgow, Scotland) are using their ReactoMate ATOM jacketed lab reactor and CondenSyn MAXI system to scale-up an innovative patent-pending process that allows them to strip out an oil from waste coffee grounds which has a very similar fatty acid profile to palm oil. Coffee is one of the most popular drinks worldwide with around two billion cups consumed every day...
Azenta Life Sciences has expanded its current multiomics services to include Olink technology, which ensures robust, multiplex protein biomarker analysis of samples in a CAP/CLIA laboratory environment. Azenta has a global footprint offering an end-to-end solution, from sample procurement and storage to sample analysis, enabling biopharma companies to accelerate scientific research...
Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS?CoV?2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can increase the stability and shelf life of complex biotherapeutics, like vaccines...
For the 27th time, the Hamburg-based life sciences company Eppendorf SE is awarding its prestigious research prize this year. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Thi Hoang Duong Nguyen, MRC Laboratory of Molecular Biology, Cambridge, UK as the winner of the Eppendorf Award for Young European Investigators 2022....
Russell Green, Lead Product Manager for Drug Discovery and SynBio at Automata outlines the four biggest trends in lab automation. Around the world, labs are full of highly trained scientists eager to make breakthrough discoveries. However, tedious tasks and shallow levels of data are currently preventing them from utilising their knowledge to its fullest capacity. At SLAS Europe last month, it was evident that...
Agilent Technologies Inc., announce that the FDA has approved a content uniformity (CU) method using the Agilent TRS100 Raman quantitative pharmaceutical analysis system. The submitting company, Teva Pharmaceutical Industries Ltd., is an Agilent Raman spectroscopy customer and global leader in generic and biopharmaceuticals. In 2021, the U.S. Food and Drug Administration (FDA) approved the company’s CU method application, which was developed using the TRS100 system...
Successful proof of concept proves analytical methods can be transferred securely between companies via cloud tackle the reproducibility crisis and advance digital transformation in R&D. The Pistoia Alliance is announcing that it has successfully completed a proof of concept (PoC) on the digital transfer via cloud of analytical High Performance Liquid Chromatography (HPLC) methods, proving it is possible to move analytical methods securely between two different vendors and Chromatography Data Systems (CDS) vendors with ease...
Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to meet the global demand for agarose resins. With this significant investment, the company will be able to manufacture and deliver continuous supply of high-quality agarose resins to develop and implement cost-effective, robust, and scalable production processes supporting novel therapies worldwide including the mRNA based Covid-19 vaccines.